SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Jensen Huangs admission of an affair with a person reportedly suspected of ties to Chinese intelligence, and Nvidias board investigation, dominate discussion. Traders debate whether the allegations create leadership or national-security risks, while many bulls dismiss the fallout as personal drama and view the selloff as a buying opportunity.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,200,877.25744775. The last known price of Ethereum is 2,141.49627095 USD and is down -4.09 over the last 24 hours. It is currently trading on 14297 active market(s) with $9,084,277,576.13 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention after a sharp decline alongside a broad crypto selloff, with traders citing leveraged-long liquidations and wider risk-off pressure; links to Nvidia headlines or Iran tensions remain speculative. Bears see further downside, while some holders view the pullback as a buying opportunity.

XRP (XRP) is a cryptocurrency . XRP has a current supply of 99,985,583,260 with 63,516,606,953 in circulation. The last known price of XRP is 1.11892236 USD and is down -3.62 over the last 24 hours. It is currently trading on 1894 active market(s) with $1,884,610,999.15 traded over the last 24 hours. More information can be found at https://xrpl.org/.

Ripple

XRPs steep decline amid a broader crypto sell-off is driving the discussion, with traders watching whether it can hold near the $1 level. Sentiment is sharply divided between dip-buyers accumulating and bearish traders warning of further losses, while many say positive Ripple-related news and anticipated catalysts have not translated into price support.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

Traders are speculating that Nvidias CEO controversy could send investors toward AMD, while the chipmakers sharp rebound after a broad AI-stock selloff adds to the attention. Some see an opening for AMD to gain as an alternative to Nvidia; others warn that Nvidia-related weakness, AI spending concerns and volatile trading could weigh on the wider chip sector.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

Ahead of TG Therapeutics Q3 results, traders are focused on whether BRIUMVI sales momentum holds and on updates about the subcutaneous formulations Phase 3 readout. Buyout and short-squeeze speculation is also prominent, though neither is confirmed.

Teva Pharmaceutical Industries Ltd. engages in the development, production, and sale of medicines. It operates through the following geographical segments: United States, Europe, and International Markets. The United States segment focuses on therapeutic area of central nervous system (CNS) portfolio, and is involved in the distribution business of generic, biosimilar and medicines, and over-the-counter (OTC) pharmaceutical products from the firm and third-party manufacturers to independent retail pharmacies, pharmacy retail chains, hospitals, and physician offices in the United States. The Europe segment offers OTC portfolio including SUDOCREM, NasenDuo, DICLOX FORTE, OLFEN Max, and FLEGAMINA brands in European Union, the United Kingdom, and certain other European countries. The International Markets segment provides its products to countries such as Canada, Israel, Russia, Latin America, and Japan. The company was founded in 1901 and is headquartered in Tel Aviv, Israel.

Teva- Pharmaceutical Industries Ltd.

Teva- Pharmaceutical Industries Ltd. - ADR

Tevas quarterly results and raised full-year outlook are driving attention, with traders highlighting growth in innovative medicines despite pressure on generics. The reaction is broadly bullish, alongside call-heavy options activity and analyst upgrades, while some are watching a pending FDA decision on at-home Igalmi use as another potential catalyst.

Summit Therapeutics, Inc. is a biopharmaceutical company, that focuses on the discovery, development, and commercialization of patient, physician, caregiver, and societal-friendly medicinal therapies intended to improve quality of life, increase potential duration of life, and resolve serious unmet medical needs. The firm conducts clinical programs focusing on Clostridioides Difficile Infection (CDI). Its lead product, Ridinilazole, is an orally administered small molecule antibiotic that is in Phase III clinical trials for the treatment of CDI. The company was founded in 2003 and is headquartered in Miami, FL.

Summit Therapeutics Inc

Summits pending FDA decision on ivonescimab plus chemotherapy for EGFR-mutated lung cancer is driving attention, with traders debating whether improved follow-up survival data can overcome the trials failure to show a statistically significant overall-survival benefit in its primary analysis. Bulls point to the progression-free-survival results and AstraZenecas backing, while bears stress the FDAs stated survival-evidence requirement, leaving approval uncertain.

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.

Vir Biotechnology Inc

Positive Phase 3 ECLIPSE-1 results for Virs hepatitis delta combination therapy are driving attention, with traders highlighting the high rate of patients reaching undetectable virus and viewing the data as support for the program. The bullish reaction has fueled speculative Gilead buyout talk, while some investors argue Vir should remain independent to develop its oncology and T-cell engager pipeline.

Direxion Shares ETF Trust - Direxion Daily Semiconductor Bull 3X ETF

Direxion Daily Semiconductor Bull 3X Shares

SOXL is drawing attention after a sharp semiconductor selloff followed by a strong rebound, amid concerns about AI spending and potential constraints on data-center expansion. Traders are split between buying the washout and viewing the bounce as temporary, with uncertainty around Nvidia-related headlines adding to volatility.

VanEck ETF Trust - VanEck Gold Miners ETF

VanEck Gold Miners ETF

A sharp rebound in gold miners, alongside golds recovery above the $4,000 level, has put GDX in focus, with traders noting strong gains and call activity. The community is split between expecting the bounce to continue and warning that the rally may be a short-term recovery amid rate, yield, and technical headwinds.

statis crypto Watchlist

Bitcoin

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$APP needs 330 test first before next leg up

TopOptionsAlerts®

תמיר איתן

Dylan

Jeremy Sanchez

SCOW BOLERO

StockTwits for iOS

Applovin Corp

MomentumWins

@MomentumWins $330? so you say sell now and buy back later or what?

StockTwits Web

 $330? so you say sell now and buy back later or what?